BUY Krishna Institute of Medical Sciences Limited — Sahi Research
bySahi ResearchHorizon: NA (inferred Swing (≤2wk))13 Nov 2026via Sahi Research Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·14 Nov · today
Krishna Institute of Medical Sciences Q2 Revenue Rises 41.3%
NewsGoogle News·11 Nov · 4d ago
KIMS Hospital Q2 operating revenue rises 39.9% to Rs 1,344 crore
NewsGoogle News·11 Nov · 4d ago
KIMS Q2 net profit rises 12% to ₹75 crore, revenue jumps 40% but margin declines
NewsCnbc-Tv18·4 Nov · 1w ago
Krishna Institute of Medical Sciences reported Q2 FY27 consolidated revenue of INR 1,363 crore, up 41.3% YoY, and EBITDA of INR 279 crore, up 34% YoY. PAT reached INR 76 crore.
BSE · Company Update·4 Nov · 1w ago
The company announced the merger of its wholly owned subsidiary, KHPL, with the holding company.
BSE · Company Update·4 Nov · 1w ago
Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
NSE · Outcome of Board Meeting·4 Nov · 1w ago
RSI at 74 — overbought territory
Technicals · rsi·14 Nov · today
Krishna Institute of Medical Sciences Limited Just Missed Earnings - But Analysts Have Updated Their Models
NewsGoogle News·8 Nov · 6d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — ICICI Securities6 Nov 2026 · ~1 year · target ₹885 · Active
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~3 months · target ₹800 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
More from Sahi Research
- BUY Adani Energy Solutions13 Nov 2026 · ~2 weeks · target ₹1,500 · Active
- BUY Radico Khaitan12 Nov 2026 · ~2 weeks · target ₹4,685 · Active
- BUY Samvardhana Motherson International9 Nov 2026 · ~2 weeks · target ₹170 · Active
- BUY Zen Technologies6 Nov 2026 · ~3 months · target ₹1,925 · Active
- BUY Adani Green Energy6 Nov 2026 · ~3 months · target ₹1,590 · Active

